We are advancing cancer diagnostics through our innovative technologies. Specializing in Circulating Tumor Cells (CTC) detection, our solutions are designed to enhance the accuracy and efficiency of cancer treatment decisions, particularly in breast cancer care. By integrating advanced microfluidics, optoelectronics, and machine learning, we are pioneering a new era of personalized medicine that offers clinicians real-time data to guide therapy choices.
Copyright © 2024 OptoSense